233 related articles for article (PubMed ID: 22207051)
1. Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Tausch C; Taucher S; Dubsky P; Seifert M; Reitsamer R; Kwasny W; Jakesz R; Fitzal F; Filipcic L; Fridrik M; Greil R; Gnant M
Ann Surg Oncol; 2012 Jun; 19(6):1808-17. PubMed ID: 22207051
[TBL] [Abstract][Full Text] [Related]
2. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
[TBL] [Abstract][Full Text] [Related]
3. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.
Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY
Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513
[TBL] [Abstract][Full Text] [Related]
4. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
Hong R; Dai Z; Zhu W; Xu B
PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
[TBL] [Abstract][Full Text] [Related]
5. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
[TBL] [Abstract][Full Text] [Related]
6. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of metastatic axillary lymph node ratio in node-positive breast cancer treated by breast conserving surgery].
Zheng Y; Chen Q; Liang Z; Jia M; Cao X
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):41-6. PubMed ID: 25877318
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
[TBL] [Abstract][Full Text] [Related]
11. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
[TBL] [Abstract][Full Text] [Related]
13. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
[TBL] [Abstract][Full Text] [Related]
14. [The association of metastasis-related indexes of lymph nodes and the prognosis of stage N2b colorectal cancer patients].
Zheng W; Zhang L; Wu YL; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):679-683. PubMed ID: 30293393
[No Abstract] [Full Text] [Related]
15. Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.
Yang C; Liu F; Li S; Li W; Zhai L; Ren M; Li Y; Lang R; Fan Y; Zhang X; Fu L
Int J Surg Pathol; 2012 Dec; 20(6):546-54. PubMed ID: 22736300
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of extracapsular invasion of axillary lymph nodes combined with peritumoral vascular invasion in patients with breast cancer.
Yajima R; Fujii T; Yanagita Y; Fujisawa T; Miyamoto T; Hirakata T; Tsutsumi S; Iijima M; Kuwano H
Ann Surg Oncol; 2015 Jan; 22(1):52-8. PubMed ID: 25059790
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.
Bai LS; Chen C; Gong YP; Wei W; Tu Y; Yao F; Li JJ; Wang LJ; Sun SR
Asian Pac J Cancer Prev; 2013; 14(2):753-7. PubMed ID: 23621232
[TBL] [Abstract][Full Text] [Related]
19. Positive nonsentinel lymph nodes are associated with poor survival in breast cancer: results from a retrospective study.
Si P; Zhang P; Chen T; Liu G; Lu H; Chen H; Wang C; Zhai B; Li W
Clin Transl Oncol; 2019 Aug; 21(8):1085-1092. PubMed ID: 30632009
[TBL] [Abstract][Full Text] [Related]
20. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer.
Fleming ND; Soliman PT; Westin SN; dos Reis R; Munsell M; Klopp AH; Frumovitz M; Nick AM; Schmeler K; Ramirez PT
Int J Gynecol Cancer; 2015 Oct; 25(8):1437-44. PubMed ID: 26332387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
